What is it about?
Prophylaxis for children with Hemophilia at low dose factors is feasible in a resource poor setting and is far superior to the conventional on demand treatment
Featured Image
Why is it important?
More than 95% of treatment in the developing world is now on demand. We worked out a simple strategy for prophylaxis in real world setting which can be emulated quite easily in a resource poor setting
Perspectives
This publication is on our experience on a cohort of children with haemophilia with low dose factor VIII and IX prophylaxis. The background was resource limitation. The result showed,tht prophylaxis, even in low doses, is far superior to on demand treatment. We believe this is a model which the developing world can emulate
Neeraj Sidharthan
Amrita Vishwa Vidyapeetham
Read the Original
This page is a summary of: Low-dose prophylaxis for children with haemophilia in a resource-limited setting in south India-A clinical audit report, Haemophilia, May 2017, Wiley,
DOI: 10.1111/hae.13272.
You can read the full text:
Contributors
The following have contributed to this page
